Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer
Clinical trial NCT02366130 · COMPLETED
Trial details
- NCT number
- NCT02366130
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-11
- Primary completion
- 2020-12-16
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.